All News

    Oncolytic Virus Clinical Trial Opens for Patients With Advanced Breast Cancer

    December 17th 2021

    City of Hope has opened its first-in-human clinical trial for an investigational therapy in patients with advanced breast cancer.

    Venclexta Demonstrates ‘Very Impressive’ Responses for Patients With Waldenström Macroglobulinemia

    December 16th 2021

    The drug Venclexta may address an unmet need for patients with Waldenström macroglobulinemia via a non-chemotherapeutic, safe and effective treatment option.

    Cancer Survivors Obtain Similar Immune Response to HPV Vaccine as General Population

    December 16th 2021

    The vaccine, which protects patients from seven different strains related to HPV-related cancers, may be considered part of routine oncology care for survivors.

    What the 12 Days of Christmas Looks Like for a Cancer Caregiver

    December 16th 2021

    A caregiver writes a poem expressing joy over her daughter’s clean scan results after having had breast cancer in her own version of the 12 Days of Christmas.

    LeVar Burton Helping the MPN Community Through Advocacy and Storytelling

    December 16th 2021

    On this episode of the “Cancer Horizons” podcast, LeVar Burton sits down with CURE® to talk about the importance of MPN awareness and the power of storytelling in advocacy.

    Keytruda May Increase Amount of Patients ‘Who May Be Cured’ of Kidney Cancer, But Expert Notes Questions Remain

    December 16th 2021

    Although the recent FDA approval of Keytruda was exciting for high-risk, nonmetastatic renal cell carcinoma, an expert from The University of MD Anderson Cancer Center notes more work is needed, particularly when it comes to individualizing treatment.

    Top 5 Skin Cancer-Related Articles of 2021

    December 15th 2021

    Here’s a look back at CURE®’s top-performing melanoma content from the year 2021.

    CAR-T Cell Therapy Continues to Impress in Myeloma Treatment

    December 15th 2021

    Treatment with the CAR-T cell therapy ciltacabtagene autoleucel (cilta-cel) led to a 97.9% response rate at two years in patients with relapsed/refractory myeloma in a recent clinical trial.

    Making the Decision to Get a COVID-19 Booster Shot as a Patient With Cancer

    December 15th 2021

    A man who has spent five years dealing with cancer shares his thoughts on the COVID-19 booster shot.

    Venclexta-Triplet Combo Appears Safe And Shows Deep Responses in Type of Relapsed/Refractory Multiple Myeloma

    December 15th 2021

    Two different doses of Venclexta combined with Darzalex and the steroid dexamethasone elicited effective responses appeared safe in patients with t(11;14) relapsed/refractory multiple myeloma.

    New Treatment Regimen May Reduce GvHD, the ‘Most Common and Feared Complication’ of Stem Cell Transplantation

    December 14th 2021

    The addition of a drug commonly used to treat arthritis may reduce the risk of graft-versus-host-disease in patients who underwent haploidentical allogeneic stem cell transplant.

    Calquence Remains Effective and Safe After 3 Years Compared With Standard of Care in Relapsed/Refractory Chronic Lymphocytic Leukemia

    December 14th 2021

    Calquence, a next-generation BTK inhibitor, significantly prolonged survival compared with standard of care, along with no new side effects at three years in chronic lymphocytic leukemia. These findings also pertained to some patients with high-risk genetic features.

    Cancer Holds All the Cards but One: Hope

    December 14th 2021

    A pancreatic cancer survivor explains the anguish he felt over seeing a young mother and her child in the waiting room for his oncologist, and what words of advice he would offer her.

    Cancer Centers Should Adopt the Reality That Cancer Has No Gender, Expert Says

    December 14th 2021

    Dr. Don S. Dizon discusses how cancer centers can be more inclusive to the LGBTQ+ community, from the naming of the institutions to the types of magazines found in the waiting rooms.

    Imbruvica And Rituxan Bests Standard-of-Care Regimen in Patients With Previously Untreated CLL

    December 14th 2021

    The data demonstrated that the combination of Imbruvica and Rituxan conferred superior progression-free survival results in patients with previously untreated chronic lymphocytic leukemia, compared with the chemotherapies fludarabine and cyclophosphamide plus Rituxan.

    Novel Drug Plus Rituxan May Serve as ‘New Treatment Option’ for Relapsed/Refractory Lymphoma Subset

    December 13th 2021

    The use of a novel drug combination yielded positive outcomes in patients with B-cell lymphomas for whom CAR-T cell therapy or stem cell transplant isn’t an option.

    mRNA COVID-19 Vaccination Sparks Strong Antibody Response in Patients With AML and MDS

    December 13th 2021

    Most patients with acute myeloid leukemia and myelodysplastic syndrome achieved strong antibody responses to COVID-19 vaccination, according to recent study results.

    Ninlaro-Darzalex Combo Elicits Favorable Treatment Outcomes, Responses in Newly Diagnosed Multiple Myeloma

    December 13th 2021

    Treatment with Ninlaro plus Darzalex and a low dose of the steroid dexamethasone was associated with favorable responses to treatment in non-transplant eligible, intermediate-fit patients with newly diagnosed multiple myeloma.

    Holiday Traditions May Change After a Loved One Dies From Cancer, But The Memories Remain

    December 13th 2021

    A cancer survivor explains how his holiday traditions changed after his wife was sick with and eventually died from cancer, and why each changing tradition holds a special place in his heart.

    Patients With Neuroendocrine Tumors May ‘Achieve the Cure’ With Liver-Directed Therapies

    December 13th 2021

    For patients with neuroendocrine tumors that have spread, curating a liver-directed approach may make their treatment process less risky and less invasive, according to an expert.

    Patients With CLL Had Improved Quality of Life on Imbruvica Plus Rituxan

    December 13th 2021

    Patients with chronic lymphocytic leukemia reported improved quality of life when treated with frontline Imbruvica and Rituxan, followed by continuous treatment with Imbruvica.

    Kymriah May Be Safe and Effective in Children and Young Adults With Acute Lymphoblastic Leukemia Subtype

    December 12th 2021

    The immunotherapy Kymriah offered similar benefits in patients younger than and older than 18 years with relapsed/refractory B-cell acute lymphoblastic leukemia.

    Cancer Clinical Trial Enrollment Is Low in the US, and Patient Depression and Anxiety May Play a Role

    December 12th 2021

    Researchers found that depression and anxiety may skew patient perceptions of participating in blood cancer clinical trials, thus contributing to low enrollment throughout the United States.

    CAR-T Cell Therapy Bests Standard of Care in Health-Related Quality of Life for Patients With Lymphoma

    December 11th 2021

    Patients with large B-cell lymphoma tended to have better quality of life that continued to improve over time after receiving Breyzani compared to those given standard of care.

    Lynparza After Chemo May Not Greatly Impact Quality of Life in High-Risk Early Breast Cancer Subset

    December 11th 2021

    Although patients treated with Lynparza after chemotherapy may experience side effects such as fatigue and nausea/vomiting, these symptoms resolved after treatment was completed in patients with high-risk early breast cancer.

    Triplet Regimen Extends Time Before Brain, Spinal Cord Metastases Worsen in Patients With Breast Cancer

    December 10th 2021

    A three-drug regimen was shown to lengthen the amount of time before cancer progressed to the central nervous system — known as central nervous system progression-free survival — in certain patients with breast cancer.

    Dose Reduction of Xpovio Improves Safety and Optimizes Patient Outcomes in Myeloma

    December 10th 2021

    In recent trial results, a dose reduction of Xpovio (selinexor) was associated with longer progression-free survival and duration of response while also reducing side effects in patients with multiple myeloma.

    ‘The Shipwreck of My Life’: How a Patient With Cancer Navigated a Treacherous 2021

    December 10th 2021

    A patient with metastatic breast cancer reflects on the difficulties she faced in 2021 and why a shipwreck is the perfect metaphor for her year.

    Experimental Drug Plus Chemo Boosts Survival in HER2-Positive Metastatic Breast Cancer

    December 10th 2021

    The use of pyrotinib — an experimental drug — plus the chemotherapy capecitabine extended survival compared with Tykerb and capecitabine among patients with pretreated HER2-positive metastatic breast cancer.

    Nick Cannon’s Son Dies From Cancer, Soccer Legend Pelé Treated for Colon Cancer and More

    December 10th 2021

    From the death of Nick Cannon’s five-month-old son due to brain cancer to the late-stage diagnosis of Kansas City reporter Matt Stewart’s wife, here’s what’s happening in the cancer landscape this week.

    NEXT PAGE
    PREVIOUS PAGE